Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Sacroiliac Joint Dysfunction: later-stage trial registry
3 of 4 indexed Sacroiliac Joint Dysfunction trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Sacroiliac Joint Dysfunction: 4 US clinical trials tracked, 3 recruiting.
Sacroiliac Joint Dysfunction is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is SI-BONE, running 1 of these trials.
Enrollment posture brief
Registry condition sacroiliac-joint-dysfunction
OPEN 3 | RECR 75% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Sacroiliac Joint Dysfunction lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Sacroiliac Joint Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Sacroiliac Joint Dysfunction is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
University of New Mexi
NCT06268704
Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1
Nevro
NCT06909292
Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion
CornerLoc
NCT06487936
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
SI-BONE
NCT05870488
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Sacroiliac Joint Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Sacroiliac Joint Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Sacroiliac Joint Dysfunction page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Sacroiliac Joint Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- SI-BONE sponsors the most Sacroiliac Joint Dysfunction trials on record, review their full trial history before evaluating a specific study. See SI-BONE's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sacroiliac Joint Dysfunction condition card totals 4 registered trials; most-linked intervention Use of iFuse TORQ; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.